Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar development and commercialization, for the commercialization of Tuznue® (trastuzumab) across Latin American markets, including Argentina, Mexico, Bolivia, and Paraguay. Tuznue® is a […]

PRMB Investors with Losses Encouraged to Contact the Firm A securities class action lawsuit has been filed against beverage company Primo Brands Corporation (NYSE: PRMB) in the wake of its troubled merger with BlueTriton Brands. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The suit seeks to represent investors who purchased or otherwise acquired the common stock of Primo Water between June

EdTech Company Stride Inc. is accused of misleading investors with inflated metrics and obscuring operational flaws that led to a massive stock decline Stride, Inc. (NYSE: LRN), one of the nation's largest providers of online educational services, is now facing a securities class action lawsuit from shareholders after a series of disclosures revealed significant operational

Telix Pharmaceuticals Ltd. (NASDAQ: TLX), a commercial-stage biopharmaceutical company specializing in diagnostic and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit following a series of regulatory setbacks and steep stock declines over the summer. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg Hagens Berman is actively investigating the allegations and urges Telix investors who suffered substantial losses to

A report from 1dai1lu.cn. “The waves are rising on deeper waters.” In 2025, global business is entering a singular moment for leaders of Chinese heritage – a shift from isolated individual achievements to a systemic presence across multinational corporations, international organizations, and institutions that shape global rules. Their influence increasingly transcends wealth and innovation, extending

(Neo:FCS-UN.NE),(Neo:FGX.NE),(Neo:FCS-UN),(Neo:FGX), Toronto, ON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Faircourt Asset Management Inc., as Manager of the Faircourt Fund (CBOE:FGX), is pleased to announce the monthly distribution payable on the Shares of the below listed Fund. Faircourt Funds Trading Symbol Distribution Amount (per share/unit) Ex-Dividend Date Record Date Payable Date Faircourt Gold Income Corp. FGX

Central Point School District 6 is notifying the community of a data security incident in May of 2025 that may have affected personal information in its possession. The District is providing this notification so that potentially affected individuals can learn more about what happened and take steps to protect their information, including information about how

Faircourt Asset Management Inc. Announces November Distribution GlobeNewswire November 26, 2025 Toronto, ON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Faircourt Asset Management Inc., as Manager of the Faircourt Fund (CBOE:FGX), is pleased to announce the monthly distribution payable on the Shares of the below listed Fund. Faircourt Funds Trading Symbol Distribution Amount (per share/unit) Ex-Dividend

(NASDAQ:TLX), NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — WHY: New York, N.Y., November 25, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”), of the important January 9, 2026

ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX GlobeNewswire November 26, 2025 NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — WHY: New York, N.Y., November 25, 2025. Rosen Law Firm, a global investor rights law firm,